A novel bispecific antibody therapy against colorectal cancer.

'Colorectal cancer' (CRC) is one of the leading causes of cancer-related deaths in Europe. A new antibody-based therapy developed using novel patient-derived screening technology, promises to specifically treat CRC patients with reduced side-effects.

ग्रंथसूची विवरण

में प्रकाशित:	Research'eu results magazine March, 60 (2017).
स्वरूप:	लेख
भाषा:	English